|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
2 Second Department of Internal Medicine, Oita University Faculty of Medicine, Oita, Japan
3 Third Department of Internal Medicine, Miyazaki Medical College, University of Miyazaki, Miyazaki, Japan
* To whom correspondence should be addressed. E-mail: hmukae{at}net.nagasaki-u.ac.jp.
Defensins are cysteine-rich cationic antimicrobial peptides that play an important role in innate immunity and are known to contribute to the regulation of host adaptive immunity. In addition to direct antimicrobial activities, it has been recently reported that
-defensins, mainly present in neutrophils in the lung, have a cytotoxic effect and induce IL-8 production from airway epithelial cells. Though
-defensins are expressed in epithelial cells in various tissues, including lung, there are no reports of their effects on cytokine
synthesis in airway epithelial cells. The aim of the present study was to determine the effects of both
- and
-defensins on the cytokine production, transcription factor binding activity and cytotoxicity in primary cultured human bronchial epithelial cells (HBECs). We used human neutrophil peptide-1 (HNP-1;
defensin) and human
-defensin-2 (HBD-2) to stimulate HBECs. The results showed that treatment of HBECs with HNP-1, but not HBD-2, increased IL-8 and IL-1
mRNA expression in a dose-dependent manner and also enhanced IL-8 protein secretion and NF-
B DNA binding activity. The 24 h treatment with >20 µg/ml of HNP-1 or >50 µg/ml of HBD-2
were cytotoxic to HBECs. These results suggest that
- and
-defensins have different
effects on cytokine synthesis by airway epithelial cells and we speculate that they play different roles in inflammatory lung diseases.
This article has been cited by other articles:
![]() |
K. Quinn, M. Henriques, T. Parker, A. S. Slutsky, and H. Zhang Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1817 - H1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishimoto, H. Mukae, N. Sakamoto, M. Amenomori, T. Kitazaki, Y. Imamura, H. Fujita, H. Ishii, S. Nakayama, K. Yanagihara, et al. Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin J. Antimicrob. Chemother., October 18, 2008; (2008) dkn427v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Huang, R. L. Redfern, S. Narayanan, R. Y. Reins, and A. M. McDermott In Vitro Activity of Human {beta}-Defensin 2 against Pseudomonas aeruginosa in the Presence of Tear Fluid Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3853 - 3860. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. McMorran, S. A. Ouvry Patat, J. B. Carlin, K. Grimwood, A. Jones, D. S. Armstrong, J. C. Galati, P. J. Cooper, C. A. Byrnes, P. W. Francis, et al. Novel Neutrophil-Derived Proteins in Bronchoalveolar Lavage Fluid Indicate an Exaggerated Inflammatory Response in Pediatric Cystic Fibrosis Patients Clin. Chem., October 1, 2007; 53(10): 1782 - 1791. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamaguchi, T. Nagase, T. Tomita, K. Nakamura, S. Fukuhara, T. Amano, H. Yamamoto, Y. Ide, M. Suzuki, S. Teramoto, et al. beta-Defensin overexpression induces progressive muscle degeneration in mice Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2141 - C2149. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vaschetto, J. Grinstein, L. Del Sorbo, A. A. Khine, S. Voglis, E. Tullis, A. S. Slutsky, and H. Zhang Role of human neutrophil peptides in the initial interaction between lung epithelial cells and CD4+ lymphocytes J. Leukoc. Biol., April 1, 2007; 81(4): 1022 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Khine, L. Del Sorbo, R. Vaschetto, S. Voglis, E. Tullis, A. S. Slutsky, G. P. Downey, and H. Zhang Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway Blood, April 1, 2006; 107(7): 2936 - 2942. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |